When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RLAY - Neoleukin Therapeutics: De Novo Protein Design Platform
Relay Therapeutics Inc.
Neoleukin is a leader in de novo drug design. The company's lead asset was recently put on clinical hold, pending more dosing data, creating a window to buy the stock.
The company has the platform potential to expand their pipeline to a wide-range of protein therapeutics for cancer and beyond.
If the company can make clinical progress, Neoleukin is positioned to potentially monopolize, both talent and drugs, the de novo design industry.